• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An Unusual Case of Gynecomastia Associated With Subclinical Hyperthyroidism.一例与亚临床甲状腺功能亢进相关的男性乳腺增生罕见病例。
Cureus. 2024 Jan 9;16(1):e51969. doi: 10.7759/cureus.51969. eCollection 2024 Jan.
2
EAA clinical practice guidelines-gynecomastia evaluation and management.EAA 临床实践指南-男性乳房发育症的评估和管理。
Andrology. 2019 Nov;7(6):778-793. doi: 10.1111/andr.12636. Epub 2019 May 16.
3
Unilateral gynecomastia as an initial presentation of hyperthyroid Graves' disease.单侧乳腺增生作为甲状腺功能亢进型格雷夫斯病的首发表现。
Endocrinol Diabetes Metab Case Rep. 2021 Nov 1;2021. doi: 10.1530/EDM-20-0140.
4
Gynecomastia as a presenting symptom of Graves' disease in a 49-year-old man.男性乳房发育作为一名49岁男性格雷夫斯病的首发症状。
Endocrinol Diabetes Metab Case Rep. 2021 Apr 1;2021. doi: 10.1530/EDM-20-0181.
5
An Intriguing Case of Gynecomastia in an Elderly Male as the Initial Presentation of Graves' Disease: A Case Report.老年男性以男性乳腺增生为格雷夫斯病首发表现的罕见病例:一例报告
Cureus. 2023 May 21;15(5):e39286. doi: 10.7759/cureus.39286. eCollection 2023 May.
6
[Phenotype of patients with gynecomastia].[男性乳房肥大症患者的表型]
Endokrynol Pol. 2008 Mar-Apr;59(2):131-9.
7
Graves' Disease Presenting as a Unilateral Breast Mass.以单侧乳腺肿块为表现的格雷夫斯病
Case Rep Med. 2022 Dec 22;2022:6641661. doi: 10.1155/2022/6641661. eCollection 2022.
8
[A 35-year-old man with gynaecomastia as the first symptom of hyperthyroidism].[一名35岁男性,以男性乳房发育作为甲状腺功能亢进的首发症状]
Ned Tijdschr Geneeskd. 2002 Feb 2;146(5):222-4.
9
Gynecomastia in a Patient Taking Meloxicam-A Case Report.服用美洛昔康的患者出现男性乳房发育症:病例报告。
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720952622. doi: 10.1177/2150132720952622.
10
[Changes of sex hormones and sex hormone-binding globulin levels in male adults with hyperthyroidism before and after antithyroid drug treatment].[抗甲状腺药物治疗前后成年男性甲状腺功能亢进症患者性激素及性激素结合球蛋白水平的变化]
Zhonghua Yi Xue Za Zhi. 2019 Jun 25;99(24):1875-1880. doi: 10.3760/cma.j.issn.0376-2491.2019.24.008.

引用本文的文献

1
Endocrine Hormones and Their Impact on Pubertal Gynecomastia.内分泌激素及其对青春期男性乳房发育的影响。
J Clin Med. 2024 Dec 30;14(1):158. doi: 10.3390/jcm14010158.

本文引用的文献

1
Painless thyroiditis following mRNA vaccination for COVID-19.新冠病毒mRNA疫苗接种后的无痛性甲状腺炎。
Hormones (Athens). 2022 Jun;21(2):335-337. doi: 10.1007/s42000-021-00346-7. Epub 2022 Jan 15.
2
Unilateral gynecomastia as an initial presentation of hyperthyroid Graves' disease.单侧乳腺增生作为甲状腺功能亢进型格雷夫斯病的首发表现。
Endocrinol Diabetes Metab Case Rep. 2021 Nov 1;2021. doi: 10.1530/EDM-20-0140.
3
New aspects in the pathogenesis and management of subacute thyroiditis.亚急性甲状腺炎发病机制和治疗的新方面。
Rev Endocr Metab Disord. 2021 Dec;22(4):1027-1039. doi: 10.1007/s11154-021-09648-y. Epub 2021 May 5.
4
Gynecomastia as a presenting symptom of Graves' disease in a 49-year-old man.男性乳房发育作为一名49岁男性格雷夫斯病的首发症状。
Endocrinol Diabetes Metab Case Rep. 2021 Apr 1;2021. doi: 10.1530/EDM-20-0181.
5
Subclinical Hyperthyroidism.亚临床甲状腺功能亢进症
N Engl J Med. 2018 Jun 21;378(25):2411-2419. doi: 10.1056/NEJMcp1709318.
6
Gynecomastia and hormones.男性乳房发育症与激素
Endocrine. 2017 Jan;55(1):37-44. doi: 10.1007/s12020-016-0975-9. Epub 2016 May 4.
7
CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 38-2015. A 21-Year-Old Man with Fatigue and Weight Loss.马萨诸塞州总医院病例记录。病例38 - 2015。一名21岁伴有疲劳和体重减轻的男性。
N Engl J Med. 2015 Dec 10;373(24):2358-69. doi: 10.1056/NEJMcpc1506821.
8
Role of genetic and non-genetic factors in the etiology of Graves' disease.遗传和非遗传因素在格雷夫斯病病因学中的作用。
J Endocrinol Invest. 2015 Mar;38(3):283-94. doi: 10.1007/s40618-014-0214-2. Epub 2014 Nov 25.
9
Bilateral gynecomastia: A rare presentation of thyrotoxicosis.双侧男性乳房发育:甲状腺毒症的一种罕见表现。
Indian J Endocrinol Metab. 2013 Mar;17(2):357-8. doi: 10.4103/2230-8210.109680.
10
Gynaecomastia as the initial presentation of thyrotoxicosis.男性乳房发育作为甲状腺毒症的首发表现。
Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S352-3. doi: 10.4103/2230-8210.104089.

一例与亚临床甲状腺功能亢进相关的男性乳腺增生罕见病例。

An Unusual Case of Gynecomastia Associated With Subclinical Hyperthyroidism.

作者信息

Rojas Pedro L, Ucar Rumeysa, Nessa Lutfor, Perez Maria C, Suravajjala Devi

机构信息

Internal Medicine, Texas Tech University Health Sciences Center, Odessa, USA.

Medical School, University of Pamplona, Cúcuta, COL.

出版信息

Cureus. 2024 Jan 9;16(1):e51969. doi: 10.7759/cureus.51969. eCollection 2024 Jan.

DOI:10.7759/cureus.51969
PMID:38333441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10853011/
Abstract

Gynecomastia in males is a medical condition that manifests as the abnormal enlargement of male breast tissue and has a variety of potential causes, which mainly classify as physiologic (infancy, puberty, elderly) and pathologic (hyperthyroidism, medications, cirrhosis, chronic kidney disease (CKD), malignancies). Pathologic causes mainly result from hormonal imbalances. While gynecomastia has been documented in cases of Graves' disease, it is rarely the presenting symptom with very few cases reported in the literature. Here we report an uncommon case of a 65-year-old male with bilateral gynecomastia who presented to his primary care physician (PCP) with concern for breast sensitivity and enlargement. Ultrasound of his breasts showed bilateral findings consistent with gynecomastia. Initial lab demonstrated suppressed thyroid-stimulating hormone (TSH) levels high, normal FT4, elevated estradiol level, elevated sex hormone-binding globulin (SHBG), and elevated total testosterone. The patient was seen by an Endocrinologist six months post-symptom onset and reported that his symptoms had resolved spontaneously.

摘要

男性乳腺增生是一种医学病症,表现为男性乳腺组织异常增大,有多种潜在病因,主要分为生理性(婴儿期、青春期、老年期)和病理性(甲状腺功能亢进、药物、肝硬化、慢性肾病(CKD)、恶性肿瘤)。病理性病因主要由激素失衡引起。虽然在格雷夫斯病病例中已记录有乳腺增生,但它很少是首发症状,文献报道的病例极少。在此,我们报告一例罕见病例,一名65岁男性患有双侧乳腺增生,因乳房敏感和增大就诊于他的初级保健医生(PCP)。他乳房的超声检查显示双侧结果符合乳腺增生。初始实验室检查显示促甲状腺激素(TSH)水平被抑制、FT4正常、雌二醇水平升高、性激素结合球蛋白(SHBG)升高以及总睾酮升高。症状出现六个月后,内分泌科医生对该患者进行了诊治,患者报告其症状已自行缓解。